Literature DB >> 24972909

A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders.

Lena Hedlund1, Amanda Lundvik Gyllensten, Lars Hansson.   

Abstract

Fatigue is frequently reported by patients with mental illness. The multidimensional fatigue inventory (MFI-20) is a self-assessment instrument with 20 items including five dimensions of fatigue. The purpose of this study was to examine the test-retest reliability, internal consistency, convergent construct validity and feasibility of using MFI-20 in patients with schizophrenia spectrum disorders. Patients completed two self-assessment instruments, MFI-20 (n = 93) and Visual Analogue Scale (n = 79), twice within 1 week ± 2 days. Fifty-three patients also rated the feasibility of responding to the MFI-20 with a Likert scale. The test-retest reliability and validity were analysed by using Spearman's correlations and internal consistency by calculating Cronbach's α. The test-retest showed a correlation between .66 and .91 for all subscales of MFI. The internal consistency was .92. The analysis of convergent construct validity showed a correlation of .68 (time 1) and .77 (time 2). No item was systematically identified as being difficult to answer.

Entities:  

Mesh:

Year:  2014        PMID: 24972909     DOI: 10.1007/s10597-014-9746-3

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  20 in total

1.  Fatigue after myocardial infarction: relationships with indices of emotional distress, and sociodemographic and clinical variables.

Authors:  Pia Alsén; Eva Brink; Yvonne Brändström; Björn W Karlson; Lars-Olof Persson
Journal:  Int J Nurs Pract       Date:  2010-08       Impact factor: 2.066

Review 2.  Considerations in determining sample size for pilot studies.

Authors:  Melody A Hertzog
Journal:  Res Nurs Health       Date:  2008-04       Impact factor: 2.228

3.  A positive concept of health - interviews with patients and practitioners in an integrative medicine clinic.

Authors:  Jennifer Hunter; Jack Marshall; Katherine Corcoran; Stephen Leeder; Kerryn Phelps
Journal:  Complement Ther Clin Pract       Date:  2013-08-24       Impact factor: 2.446

4.  The impact of fatigue on cognitive functioning in patients with multiple sclerosis.

Authors:  Yvonne Bol; Annelien A Duits; Raymond M M Hupperts; Inge Verlinden; Frans R J Verhey
Journal:  Clin Rehabil       Date:  2010-06-24       Impact factor: 3.477

5.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; L A Alvarez; N G LaRocca; L C Scheinberg
Journal:  Arch Neurol       Date:  1988-04

6.  Insomnia is frequent in schizophrenia and associated with night eating and obesity.

Authors:  Laura B Palmese; Pamela C DeGeorge; Joseph C Ratliff; Vinod H Srihari; Bruce E Wexler; Andrew D Krystal; Cenk Tek
Journal:  Schizophr Res       Date:  2011-12       Impact factor: 4.939

7.  Development of a clinical global impression scale for fatigue.

Authors:  Steven D Targum; Howard Hassman; Maria Pinho; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2012-01-10       Impact factor: 4.791

8.  Assessment of fatigue in patients with fibromyalgia and chronic widespread pain. Reliability and validity of the Swedish version of the MFI-20.

Authors:  Anna Ericsson; Kaisa Mannerkorpi
Journal:  Disabil Rehabil       Date:  2007-11-30       Impact factor: 3.033

9.  Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease.

Authors:  S O Breukink; J H Strijbos; M Koorn; G H Koëter; E H Breslin; C P van der Schans
Journal:  Respir Med       Date:  1998-04       Impact factor: 3.415

10.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

Authors:  E M Smets; B Garssen; B Bonke; J C De Haes
Journal:  J Psychosom Res       Date:  1995-04       Impact factor: 3.006

View more
  6 in total

1.  Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.

Authors:  Rana Fadhil Mousa; Hussein Kadhem Al-Hakeim; Amer Alhaideri; Michael Maes
Journal:  Metab Brain Dis       Date:  2020-09-23       Impact factor: 3.584

2.  Effects of the health belief model following acute exacerbation of chronic obstructive pulmonary disease in a hospital in China.

Authors:  Mei Ji; Ai-Hong Wang; Jun Ye; Ya-Hui Shen; Chun-Mei Chen; Chen Yu; Li-Fang Li
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY).

Authors:  Stéphane Raffard; Nicolas Rainteau; Sophie Bayard; Yasmine Laraki; Joanna Norton; Delphine Capdevielle
Journal:  Trials       Date:  2020-09-17       Impact factor: 2.279

Review 4.  Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions.

Authors:  Ruel Billones; Josephine K Liwang; Kierra Butler; Letitia Graves; Leorey N Saligan
Journal:  Brain Behav Immun Health       Date:  2021-05-21

5.  Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.

Authors:  Camilla Binz; Alma Osmanovic; Susanne Petri; Olivia Schreiber-Katz; Nele H Thomas; Benjamin Stolte; Maren Freigang; Isabell Cordts; Ramona Griep; Zeljko Uzelac; Claudia D Wurster; Christoph Kamm; Hannah A Siegler; Gary Wieselmann; Andreas Hermann; Paul Lingor; Marcus Deschauer; Albert C Ludolph; Thomas Meyer; René Günther; Tim Hagenacker
Journal:  Ann Clin Transl Neurol       Date:  2022-02-22       Impact factor: 4.511

6.  Validation of the Multidimensional Fatigue Inventory with Coronary Artery Disease Patients.

Authors:  Julija Gecaite-Stonciene; Adomas Bunevicius; Julius Burkauskas; Julija Brozaitiene; Julius Neverauskas; Narseta Mickuviene; Nijole Kazukauskiene
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.